R&D Status

Through years of expertise, team of top class scientists, and innovative solutions, Immunobiome is positioned to be the leader in the field of microbiome-targeted therapeutics.


cutting edge Worldclass infrastructure

Established germ-free mouse-derived immune response index system
Validate the specific immune response using germ-free mice (immunotyping technology)
Use immune markers to identify anti-cancer and anti-inflammatory effects 


Humanized microbiome model to analyze efficacy and establish clinical indicators


Establishment of system for identification of microorganism-derived active substances and mechanisms of action


Development of methods to measure immune modulatory effects of cultured microbes and use in active substance-based quality control